Razumab is a recombinant humanized monoclonal antibody fragment designed for intraocular use to treat retinal disorders like wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema and myopic choroidal neovascularization.
Razumab binds to a protein called vascular endothelial growth factor (VEGF). It inhibits the action of VEGF and the growth of abnormal blood vessels in the eye. These abnormal blood vessels are responsible for the loss of vision as they cause leakage into the retina.
Razumab is approved to treat wet age-related macular degeneration (AMD). It is also used to treat macular edema due to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO), Myopic choroidal neovascularization and diabetic macular edema due to diabetic retinopathy.
Razumab may cause infection and inflammation in the eye, retinal detachment and cataract. Other side effects include:
If your eye develops redness, pain, sensitive to light or if you observe a change in vision, inform your doctor immediately.
Razumab is contraindicated in patients with ocular or periocular infections or in patients with known hypersensitivity to razumab or any of the excipients in Razumab.
You should immediately inform or see your doctor if you miss to receive your razumab injection.
Chances of overdose are rare as this drug is given by the doctor. However, doses as high as 2 mg razumab in 0.05 mL have been administered to patients and there were no additional unexpected adverse reactions.
Corporate House, Near Sola Bridge, S.G. Highway, Thaltej, Ahmedabad-380054, Gujarat, INDIA.
MEDICAL DISCLAIMER
All content found on the razumab.co.in website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The content is not intended or meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 102 immediately. razumab.co.in does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on razumab.co.in. Reliance on any information provided by razumab.co.in, employees, contracted writers, or medical professionals presenting content for publication to razumab.co.in is solely at your own risk. The site may contain health- or medical-related materials or discussions regarding Eye diseases. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis. Links to educational content not created by razumab.co.in are taken or accessed at your own risk. razumab.co.in is not responsible for the claims of external websites and education companies.
Disclaimer: User data will be collected for better functionality and user response and data included in the chatbot will be kept confidential and will not be shared elsewhere.
